Visualization of size-dependent tumour retention of PEGylated nanographene oxide via SPECT imaging

2016 ◽  
Vol 4 (39) ◽  
pp. 6446-6453 ◽  
Author(s):  
Tianye Cao ◽  
Peihong You ◽  
Xiaobao Zhou ◽  
Jianmin Luo ◽  
Xiaoping Xu ◽  
...  

Sub-50 nm usNGO–PEG was confirmed to be the favorable size for faster and higher cellular uptake and efficient tumor accumulation than over-50 nm NGO–PEG.

2018 ◽  
Vol 46 (sup3) ◽  
pp. S956-S963 ◽  
Author(s):  
Sushant Singh ◽  
Anh Ly ◽  
Soumen Das ◽  
Tamil S. Sakthivel ◽  
Swetha Barkam ◽  
...  

ChemBioChem ◽  
2019 ◽  
Vol 21 (4) ◽  
pp. 496-499 ◽  
Author(s):  
Isabell Kemker ◽  
Rebecca C. Feiner ◽  
Kristian M. Müller ◽  
Norbert Sewald

2009 ◽  
Vol 1236 ◽  
Author(s):  
Hengyi Xu ◽  
Zoraida Pascual Aguilar ◽  
Ben Jones ◽  
Hua Wei ◽  
Andrew Wang

AbstractThe nanotechnology is undergoing enormous attention in the areas of biological research for clinical, environmental, and life sciences applications. One of the products from this new technology that attracts researcher’s attentions is the semiconductor quantum dot (QDs) nanoparticles, QDs possess incomparable advantages such as unique size-dependent physical properties, broad absorption spectrum, precise small bandwidth emission wavelength, as well as enhanced chemical and photochemical stability. The QDs can be modified for a controlled and enhanced endocytosis, enhanced cooperative binding activity, and easy introduction of multi-functionalities for medical applications such as targeted delivery and imaging. It can be used for complex studies that play very important roles in the modern biomedical researches. However, when performing the cell related assays, the non-specific cellular uptake of QDs is a major concern because they can lead to false positives or false results. In our study, we used different surface modified QDs treated with different blocking buffers to eliminate cellular uptake. The preliminary results showed that the cellular uptake of QDs can be eliminated by surface modification of the QD materials and by performing the assays in the presence of blocking buffers. As a result of the elimination of non-specific uptake of QDs the sensitivity and specificity of detection increased significantly.


2017 ◽  
Vol 13 (3) ◽  
pp. 1011-1020 ◽  
Author(s):  
Federica Caponnetto ◽  
Ivana Manini ◽  
Miran Skrap ◽  
Timea Palmai-Pallag ◽  
Carla Di Loreto ◽  
...  

2021 ◽  
Vol Volume 16 ◽  
pp. 5167-5183
Author(s):  
Jingyi Zhu ◽  
Junxing Yang ◽  
Lingzhou Zhao ◽  
Pingping Zhao ◽  
Jiqin Yang ◽  
...  

Materials ◽  
2020 ◽  
Vol 13 (3) ◽  
pp. 513 ◽  
Author(s):  
Francisco Silva ◽  
António Paulo ◽  
Agnès Pallier ◽  
Sandra Même ◽  
Éva Tóth ◽  
...  

Gold nanoparticles (AuNPs) are interesting for the design of new cancer theranostic tools, mainly due to their biocompatibility, easy molecular vectorization, and good biological half-life. Herein, we report a gold nanoparticle platform as a bimodal imaging probe, capable of coordinating Gd3+ for Magnetic Resonance Imaging (MRI) and 67Ga3+ for Single Photon Emission Computed Tomography (SPECT) imaging. Our AuNPs carry a bombesin analogue with affinity towards the gastrin releasing peptide receptor (GRPr), overexpressed in a variety of human cancer cells, namely PC3 prostate cancer cells. The potential of these multimodal imaging nanoconstructs was thoroughly investigated by the assessment of their magnetic properties, in vitro cellular uptake, biodistribution, and radiosensitisation assays. The relaxometric properties predict a potential T1- and T2- MRI application. The promising in vitro cellular uptake of 67Ga/Gd-based bombesin containing particles was confirmed through biodistribution studies in tumor bearing mice, indicating their integrity and ability to target the GRPr. Radiosensitization studies revealed the therapeutic potential of the nanoparticles. Moreover, the DOTA chelating unit moiety versatility gives a high theranostic potential through the coordination of other therapeutically interesting radiometals. Altogether, our nanoparticles are interesting nanomaterial for theranostic application and as bimodal T1- and T2- MRI / SPECT imaging probes.


2019 ◽  
Vol Volume 14 ◽  
pp. 4247-4259 ◽  
Author(s):  
Meiyu Wu ◽  
Hongbo Guo ◽  
Lin Liu ◽  
Ying Liu ◽  
Liming Xie

2012 ◽  
Vol 23 (5) ◽  
pp. 958-965 ◽  
Author(s):  
René P. Brinkhuis ◽  
Katica Stojanov ◽  
Peter Laverman ◽  
Jos Eilander ◽  
Inge S. Zuhorn ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document